Subacute prurigo and eosinophilia in a patient with rheumatoid arthritis receiving infliximab and etanercept

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 3, 2011, Pages 248-249

  Cancelliere, N ^a   Barranco, P ^a   Vidaurrazaga C ^b   Benito, D M ^b   Quirce, S ^a  

^a Hospital Universitario   (Spain)

^b Hospital Universitario   (Spain)

Author keywords

Eosinophilia; Etanercept; Infliximab

Indexed keywords

ETANERCEPT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

AGED; BLOOD ANALYSIS; CASE REPORT; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; HUMAN; HUMAN TISSUE; LEUKOPENIA; LYMPHOCYTIC INFILTRATION; NOTE; PAPULAR URTICARIA; PATCH TEST; PRICK TEST; RHEUMATOID ARTHRITIS; SKIN BIOPSY;

AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; DRUG HYPERSENSITIVITY; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOGLOBULIN G; PRURIGO; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 79955457478     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. Maruani A, Samimi M, Lorette G. Prurigo. Prease Med. 2009;38:1099-105.
2. Chang J, Girgis L. Clinical use of anti-TNF-alpha biological agents-a guide for GPs. Aust Fam Physician 2007;36:1035-8.
3. Lee HH, Song IH, Friedrich A, Gauliard J, Röwert J. Cutaneous side-effects I patients with rheumatic diseases during application of tumour necrosis factor-αantagonists. Brit J Dermatol 2007;156:486-91.
4. Winfi eld H, Edward L. Eosinophilic cellulitislike reaction to subcutaneous Etanercept injection. Arch Dermatology 2006;142:218-20.